Feedback / Questions
Danyelza (naxitamab-gqgk) - SERB Pharmaceuticals
https://www.globenewswire.com/news-release/2025/09/16/3150821/0/en/SERB-Pharmaceuticals-Completes-Acquisition-of-Y-mAbs-Therapeutics.html
Sep 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next